Literature DB >> 10937854

Effects of perfluorophenanthrene on the human corneal endothelium.

G Gurelik1, F Akata, K Bilgihan, B Hasanreisoğlu.   

Abstract

PURPOSE: To evaluate long term effects of perfluorophenanthrene (C12F24), a perfluorocarbon fluid, in the anterior chamber of the human eye, where residual perfluorophenanthrene was retained in the eye postoperatively.
METHODS: Slit-lamp microscopic and specular microscopic examinations of 4 eyes of 4 patients were performed. All the eyes were operated for complicated retinal detachment and they were aphakic at the end of the operations. Mean follow-up period was 10 months (6-16 months).
RESULTS: Perfluorophenanthrene was seen in the anterior chamber in the first or second day postoperatively as a single drop. In the third week, postoperatively, the first signs of splitting the perfluorophenanthrene (fish egging phenomena) was observed. There was no sign of corneal or anterior segment toxicity with the slit lamp microscopic examinations and the intraocular pressure was within normal limits during the follow-up period in all eyes. However, some structural changes of the corneal endothelium were shown by specular microscopy. Decreased endothelial cell density, a reversed illumination pattern in which the normally dark cellular boundaries appear bright and intracytoplasmic light reflecting bodies were signs of cellular damage at the contact sites whereas no significant changes were seen at non contact sites.
CONCLUSION: Residual perfluorophenanthrene in the anterior chamber does not induce gross corneal damage or ocular inflammation, although structural changes indicating the damage of the corneal endothelium, can be shown by specular microscopy at the contact sites. Corneal endothelial changes seem to arise from a contact-dependent effect of the perfluorophenanthrene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10937854     DOI: 10.1023/a:1006452923513

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  15 in total

1.  Giant retinal tears. Surgical techniques and results using perfluorocarbon liquids.

Authors:  S Chang; H Lincoff; N J Zimmerman; W Fuchs
Journal:  Arch Ophthalmol       Date:  1989-05

2.  Experimental vitreous and aqueous replacement with perfluorophenanthrene. Clinical, histologic, and electrophysiologic results.

Authors:  U Stolba; K Krepler; R Pflug; M Velikay; A Wedrich; S Binder
Journal:  Retina       Date:  1997       Impact factor: 4.256

3.  Retinal microincarceration with penetrating diathermy in the management of giant retinal tears.

Authors:  G A Peyman; K R Rednam; A A Seetner
Journal:  Arch Ophthalmol       Date:  1984-04

4.  Experimental vitreous replacement with perfluorotributylamine.

Authors:  S Chang; N J Zimmerman; T Iwamoto; R Ortiz; D Faris
Journal:  Am J Ophthalmol       Date:  1987-01-15       Impact factor: 5.258

5.  Low viscosity liquid fluorochemicals in vitreous surgery.

Authors:  S Chang
Journal:  Am J Ophthalmol       Date:  1987-01-15       Impact factor: 5.258

6.  Evaluation of anterior segment tolerance to short-term intravitreal perfluoron.

Authors:  D P Han; S K Nanda; W J O'Brien; J Guy; T G Murray; H C Boldt
Journal:  Retina       Date:  1994       Impact factor: 4.256

7.  Perfluorocarbon liquid effects on corneal endothelial permeability.

Authors:  K Green; L Cheeks; J M Friedman
Journal:  Lens Eye Toxic Res       Date:  1992

8.  Treatment of giant retinal tears combined with proliferative vitreoretinopathy.

Authors:  B M Glaser
Journal:  Ophthalmology       Date:  1986-09       Impact factor: 12.079

9.  Corneal toxicity study of two perfluorocarbon liquids in rabbit eyes.

Authors:  H Moreira; J M de Queiroz; P E Liggett; P J McDonnell
Journal:  Cornea       Date:  1992-09       Impact factor: 2.651

10.  Perfluorocarbon liquids in the management of traumatic retinal detachments.

Authors:  S Chang; V Reppucci; N J Zimmerman; M H Heinemann; D J Coleman
Journal:  Ophthalmology       Date:  1989-06       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.